Loading clinical trials...
Loading clinical trials...
Registry on Hypomethylating Agents in Myeloid Neoplasms, Including Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) and Acute Myeloid Leukemia (AML)
Conditions
Interventions
non interventional
Locations
20
Austria
LKH Feldkirch, Innere Med. II, Interne E
Feldkirch, Austria
LKH Fürstenfeld
Fürstenfeld, Austria
UK Graz: Universitätsklinik für Innere Medizin; Klinische Abteilung für Hämatologie
Graz, Austria
Universitätsklinik für Innere Medizin V
Innsbruck, Austria
Klinikum Klagenfurt: 1. Medizinische Abteilung
Klagenfurt, Austria
UK Krems: Innere Medizin II
Krems, Austria
Start Date
February 9, 2009
Primary Completion Date
December 31, 2021
Completion Date
December 31, 2021
Last Updated
March 25, 2024
NCT06285890
NCT06220162
NCT04065399
NCT06859424
NCT06994676
NCT06484062
Lead Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions